Top Markets
Coin of the day
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
Rang in Aktien #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Aktienkurs
$0.20876331
Marktkapitalisierung
$1.38M
Veränderung (1 Tag)
1.15%
Veränderung (1 Jahr)
-64.84%
Land
FR
Handel IntegraGen SA (ALINT)

Kategorie

Gewinn für IntegraGen SA (ALINT)
Gewinn im Dec 2025 TTM: $-3.23M
Laut den aktuellen Finanzberichten von IntegraGen SA betragen die aktuellen Gewinne des Unternehmens $-3.23M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $-286.40K, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $-153.95K betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von IntegraGen SA von 2008 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $-3.23M 782.69%
2024 $-366.28K 27.89%
2023 $-286.40K 86.04%
2022 $-153.95K 18.42%
2021 $-130.00K -77.17%
2020 $-569.29K 15.84%
2019 $-491.43K -67.91%
2018 $-1.53M 6.75%
2017 $-1.43M -29.04%
2016 $-2.02M 0.08%
2015 $-2.02M 10.76%
2014 $-1.82M -54.01%
2013 $-3.96M 29.95%
2012 $-3.05M -5.30%
2011 $-3.22M -31.40%
2010 $-4.70M -3.84%
2009 $-4.88M -6.08%
2008 $-5.20M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
$24.72B -764,615.67%
DK
$5.17B -159,875.15%
US
$5.16B -159,602.96%
US
$2.14B -66,218.92%
BE
$1.66B -51,304.66%
NL